SkyePharma PLC: Flutiform NDA Accepted for Review

Full story: Earth Times

Flutiform NDA Accepted for Review LONDON, UK, 22 May 2009 - SkyePharma PLC today announces that the New Drug Application for its lead development product, Flutiform , an investigational treatment for persistent asthma in patients 12 years of age and older, has been accepted for review by the US Food and Drug Administration .

Leave a Comment

Comments

Type in your comments to post to the forum

Name
(appears on your post)

Comments

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Fluticasone (generic), Flovent Discussions

Topic	Updated	Last By	Comments
Fluticasone now in generic, sort of (Jun '06)	Oct 15	Sarah	69
Advair beats Spiriva in treatment of COPD (Dec '07)	Sep '09	JoyceL	41
A Single Inhaler for Your Asthma	May '09	Nikki	1
In view of the recent TORCH study results and t... (Jul '06)	May '08	Mary	4
Promising alternative to Asthma treatments deta... (May '07)	Mar '08	joyce	3
flovent (Oct '07)	Jan '08	Isabelle	3
Asthma treatment alternatives promising (May '07)	Jul '07	Michelle	4